Published trade mark details for 2613352

This information was published on 2026-01-27T00:13:51 for IP Right Acceptance Published.

Field	Value
(210)	2613352 (IR 1892970)
(220)	31 Oct 2025
(300)	US, 26 Aug 2025, 99358160
(500)	The mark consists of the stylized wording "AUJEMFLU" in dark teal, which is set in the lower right side of a gold square outline. The stylized wording "ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" in dark teal is below and to the right of the gold square outline. "ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" The color(s) dark teal and gold is/are claimed as a feature of the mark. The mark consists of the stylized wording "AUJEMFLU" in dark teal, which is set in the lower right side of a gold square outline. The stylized wording "ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE" in dark teal is below and to the right of the gold square outline.
(511) (510)	Class 5 Vaccines.
(540)
(550)	Figurative
(730)	Seqirus Inc.

 

Find out more about publications on the About page.